CCK1R Agonists: A Promising Target for the Pharmacological Treatment of Obesity

E-ISSN： 1873-4294|3|8|837-854

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.8, 2003-05, pp. : 837-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus

Current Medicinal Chemistry, Vol. 20, Iss. 21, 2013-01 ,pp. : 2609-2625

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Approaches for the Treatment of Obesity

By Fernández-López J-A.

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 915-944

Adis International

Access to resources Recommend Favorite

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

By Oberman Lindsay M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1819-1825

Informa Healthcare

Access to resources Recommend Favorite

Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC- 4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 504-538

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Treatment of Obesity in Paediatric Patients

By Daniels S.

Pediatric Drugs, Vol. 3, Iss. 6, 2001-01 ,pp. : 405-410

Adis International

Access to resources Recommend Favorite